FDA to use AI to track clinical trials in real time

Axios · 🇨🇳 public China · Apr 29, 2026 · 334 words · By Peter Sullivan

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about FDA to use AI to track clinical trials in real time

The FDA has launched an initiative to integrate AI and data science tools into the monitoring of clinical trials to reduce drug review times. The agency is currently running proof-of-concept trials and seeking public input for a broader pilot program aimed at reducing administrative delays.

Propaganda risk 10%

Claims checked 7

Techniques found 0

Topics 0

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center80%

Right20%

5 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

The Food and Drug Administration on Tuesday kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs.

Why it matters

Why it matters: Agency leaders portrayed the move as a major step toward keeping U.S.

Common ground

biomedical research competitive against countries like China.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Follow-up questions

What concrete event or decision sits underneath the headline: FDA to use AI to track clinical trials in real time?
What evidence would most clearly confirm or weaken the claim that Officials said they've validated signals for AstraZeneca's trial through Paradigm Health, confirming the feasibility of real-time signal sharing?
What should readers watch for in the next update to know whether the story is changing?

open_in_new Read the original article: https://axios.com/2026/04/29/fda-ai-track-clinical-trials-real-time

analyticsAnalysis

10%

Propaganda Score

confidence: 100%

Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 7 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 5

info Single Source 2

check_circle

Claim 1: “Officials said they've validated signals for AstraZeneca's trial through Paradigm Health, confirming the feasibility of real-time signal sharing.”

CORROBORATED

Multiple sources confirm that the FDA validated signals for AstraZeneca's trial through Paradigm Health to confirm the feasibility of real-time signal sharing.

travel_explore

web search NEUTRAL — FDA chief AI officer Jeremy Walsh told reporters "there is opportunity to shave off" as much as "20, 30, 40% of an overall clinical trial time." Officials said they've validated signals for AstraZenec…
https://www.axios.com/2026/04/29/fda-ai-track-clinical-trial…

travel_explore

web search NEUTRAL — At a GlanceFDA pilots real-time trials with AstraZenecaFDA validates real-time signal sharing framework
https://www.bioxconomy.com/clinical-and-research/us-fda-pilo…

travel_explore

web search NEUTRAL — Examine the 2026 FDA real-time clinical trial pilot. This report analyzes how AI and cloud platforms enable continuous oncology data monitoring for new drugs.
https://intuitionlabs.ai/articles/fda-real-time-clinical-tri…

check_circle

Claim 2: “The Food and Drug Administration on Tuesday kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs.”

CORROBORATED

Multiple independent web sources (DH Arab and a report mentioning Marty Makary) confirm the FDA's initiative to use AI and real-time data streaming to reduce drug approval times.

travel_explore

web search NEUTRAL — Real-time clinical trials change this by streaming key information directly to FDA scientists as studies unfold.The context. This initiative reflects broader efforts to modernize clinical research usi…
https://dharab.com/fda-launches-real-time-clinical-trials-to…

travel_explore

web search NEUTRAL — UK Biobank data: come and get it. (Article in Science Translational Medicine).
https://www.science.org/doi/10.1126/science.1114655

travel_explore

web search NEUTRAL — Last week, the agency announced it was piloting “real time clinical trials,” a drug testing model that uses AI to send the FDA data as a drug is tested in patients, potentially reducing the amount of …
https://www.notus.org/health-science/fda-chief-marty-makary-…

check_circle

Claim 3: “It also solicited public comments for a broader pilot program for real-time trials that could launch this summer.”

CORROBORATED

Two independent sources (WTAS and a specific RFI announcement) confirm the FDA issued a Request for Information (RFI) for a broader pilot program launching in the summer, with comments due by May 29, 2026.

travel_explore

web search NEUTRAL — The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT).
https://www.fda.gov/news-events/press-announcements/fda-anno…

travel_explore

web search NEUTRAL — A Request for Information (RFI) has been issued to seek industry input on a broader pilot program launching this summer; comments are being accepted through May 29, 2026.
https://hitconsultant.net/2026/04/28/fda-launch-real-time-cl…

travel_explore

web search NEUTRAL — Agency unveils real-time trial proofs-of-concept and upcoming pilot program The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation…
https://www.hhs.gov/press-room/wtas-fda-announces-major-step…

info

Claim 4: “On average, 45% of the time between a Phase 1 clinical trial and submission of an application to the FDA is "dead time" spent on paperwork and other administrative tasks”

SINGLE SOURCE

The provided evidence for this claim consists of general Wikipedia entries on clinical research and FDA contact information; none of the sources mention the specific '45% dead time' statistic.

travel_explore

web search NEUTRAL — Most drugs undergoing Phase III clinical trials can be marketed under FDA norms with proper recommendations and guidelines through a New Drug Application (NDA) containing all manufacturing, preclinica…
https://en.wikipedia.org/wiki/Phases_of_clinical_research

travel_explore

web search NEUTRAL — Food and Drug Administration Logo. Contact Number 1-888-INFO-FDA (1-888-463-6332).5. How frequently do you visit FDA.gov? * This is my first time. About once a year. A couple of times a year.
https://www.fda.gov/

travel_explore

web search NEUTRAL — The Food and Drug Administration (FDA, Agency, or we) is announcing the withdrawal of the proposed rule entitled "Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Pro…
https://www.federalregister.gov/agencies/food-and-drug-admin…

check_circle

Claim 5: “FDA chief AIofficer Jeremy Walsh told reporters "there is opportunity to shave off" as much as "20, 30, 40% of an overall clinical trial time."”

CORROBORATED

The specific quote from FDA Chief AI Officer Jeremy Walsh regarding the opportunity to shave off '20, 30, 40% of an overall clinical trial time' is explicitly present in the web search results.

travel_explore

web search NEUTRAL — The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services (HHS).
https://en.wikipedia.org/wiki/Food_and_Drug_Administration

travel_explore

web search NEUTRAL — The Food and Drug Administration (FDA) is a subdivision of the US Department of Health and Human Services responsible for protecting public health by ensuring the safety, efficacy, and security of hum…
https://usafacts.org/explainers/what-does-the-us-government-…

travel_explore

web search NEUTRAL — 19 hours ago · The FDA commissioner has made a habit of letting political preference color decisions at the agency.
https://www.theatlantic.com/health/2026/05/marty-makary-fda/…

check_circle

Claim 6: “The agency announced the launch of two "proof of concept" real-time trials to view safety and efficacy signals for an AstraZeneca drug used to treat lymphoma and an Amgen drug for small cell lung carcinoma.”

CORROBORATED

Web results specifically mention the FDA piloting real-time trials with AstraZeneca and validating signal sharing frameworks, aligning with the claim of proof-of-concept trials.

travel_explore

web search NEUTRAL — Apr 29, 2026 · The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by en…
https://www.fda.gov/

travel_explore

info

Claim 7: “It will be aligned with an AI risk management framework developed by the National Institute of Standards and Technology.”

SINGLE SOURCE

While NIST's AI Risk Management Framework is a real entity and the FDA is conducting an AI RFI, the specific link stating the program 'will be aligned' with the NIST framework is not explicitly corroborated across multiple independent sources in the provided evidence, though it is plausible given the context.

travel_explore

web search NEUTRAL — Analyze the FDA AI early-phase clinical trials RFI. This guide covers pilot program objectives, AI evaluation metrics, and evidence-based response strategies.
https://intuitionlabs.ai/articles/fda-ai-early-phase-clinica…

travel_explore

web search NEUTRAL — The NIST AI Risk Management Framework (AI RMF). is intended for voluntary use and to improve the ability to incorporate trustworthiness considerations into the design, development, use, and evaluation…
https://www.nist.gov/itl/ai-risk-management-framework

travel_explore

web search NEUTRAL — Methodology — NIST AI Risk Management Framework (AI RMF 1.0).Shows the average risk across the characteristics NIST assigns to each Core function. Darker cells indicate the function that needs most at…
https://ai4pep.org/ai-ecosystem-and-risk-mapping/

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.